FMP

FMP

Enter

FSTX - F-star Therapeutics,...

photo-url-https://images.financialmodelingprep.com/symbol/FSTX.png

F-star Therapeutics, Inc.

FSTX

NASDAQ

Inactive Equity

F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-star Therapeutics, Inc. was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.

7.12 USD

0 (0%)

FSTX Financial Statements

Year

2021

2020

2019

2018

Total Revenue

21.17M

11.26M

28.32M

0

Cost of Revenue

0

0

0

0

Gross Profit

21.17M

11.26M

28.32M

0

Operating Expenses

51.88M

33.64M

46.67M

28.47M

Research and Development

28.75M

14.13M

31.39M

19.75M

Selling, General & Administrative Expenses

23.13M

19.51M

15.28M

8.72M

Selling & Marketing Expenses

0

0

0

0

General & Administrative Expenses

23.13M

19.51M

15.28M

8.72M

Other Expenses

651k

-3.23M

-1.25M

0

Operating Income

-30.71M

-22.39M

-22.5M

-28.47M

Total Other Income/Expenses Net

-941k

-3.23M

-1.6M

5.62M

Income Before Tax

-31.66M

-25.62M

-23.75M

-22.85M

Income Tax

-372k

-1k

-737k

0

Net Income

-31.28M

-25.62M

-23.01M

-22.85M

Basic EPS

-1.88

-9.69

-2.54

-0

EPS Diluted

-1.88

-9.69

-2.54

-0

Basic Average Shares

16.65M

2.64M

9.07M

14.62B

Diluted Average Shares

16.65M

2.64M

9.07M

14.62B

EBITDA

-29.42M

-21.24M

-13.35M

-28.47M

Retained Earning Schedule

Year

2021

2020

2019

2018

Retained Earnings (Previous Year)

-47.17M

-21.55M

-102.07M

-79.21M

Net Income

-31.28M

-25.62M

-23.01M

-22.85M

Stock Repurchases

0

0

0

0

Dividend Paid

0

0

0

0

Retained Earnings

-78.45M

-47.17M

-21.55M

-102.07M

Other Distributions

-31.28M

-25.62M

80.52M

-22.85M

PPE Schedule

Year

2021

2020

2019

2018

Gross PPE

4.17M

3.57M

2.03M

2.32M

Annual Depreciation

1.29M

1.14M

9.15M

288k

Capital Expenditure

-658k

-730k

-127k

-1.97M

Net PPE

3.53M

3.16M

-6.99M

4M

Intangible and Goodwill Schedule

Year

2021

2020

2019

2018

Acquisitions and Adjustments

-28k

10.61M

4.32M

0

Goodwill (Previous Year)

14.93M

4.32M

0

0

Goodwill

14.9M

14.93M

4.32M

0

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep